MedTrace Logo

Ultrasound-guided Peripheral Intravenous Catheter Insertion Technique

NCT04218643 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 227

Last updated 2023-03-30

No results posted yet for this study

Summary

This comparative treatment study aims to challenge a current clinical practice. Specifically, whether the use of ultrasound-guided peripheral intravenous catheter insertion results in lower post insertion failure rates with longer utility time compared to peripheral intravenous catheters (PIVC) inserted in the standard manner during the emergency department (ED), observation and in-patient stay. There are two secondary aims to the study: a) determining if ultrasound-guided peripheral intravenous catheter insertion results in lower post removal complication rates compared to PIVCs inserted in the standard manner; and b) determining if catheter-to-vein ratio can predict post insertion success of PIVCs and what catheter-to-vein ratio is most successful. In this study, catheter-to-vein ratio is defined as the diameter of the lumen of the vein divided by the outside diameter of the catheter.

Conditions

  • Catheterization, Peripheral Venous
  • Phlebitis
  • Infiltration

Interventions

OTHER

Ultrasound-guided technique

IV inserted via ultrasound guidance

OTHER

Standard technique

IV inserted via standard technique

Sponsors & Collaborators

  • The Reading Hospital and Medical Center

    lead OTHER

Principal Investigators

  • Scott Leroux, BS NRP · Reading Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-11
Primary Completion
2021-10-01
Completion
2021-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04218643 on ClinicalTrials.gov